About QLT Inc
QLT Inc. (QLT), is a global biopharmaceutical company engaged in the business of discovering, developing and commercialization of therapies. QLT has two commercial products, Visudyne and Eligard. Visudyne utilizes photodynamic therapy (PDT), to treat the eye disease known as wet age related macular degeneration (wet AMD), the cause of blindness in people – more... over the age of 55 in North America and Europe. Visudyne is also used for the treatment of subfoveal choroidal neovascularization (CNV) due to pathologic myopia, or severe near-sightedness, and presumed ocular histoplasmosis or other macular diseases. The Eligard product line includes one, three, four and six month commercial formulations of Atrigel technology combined with leuprolide acetate.
(Source: 10-K) – less – More from ZoomInfo »
QLT Inc Employer Reviews
QLT Inc
Excellent biotechnology company
Manager, Business Development & Marketing (Former Employee), Vancouver, BC – July 19, 2012
QLT Inc
world class research projects
SENIOR R&D ENGINEER (Current Employee), menlo park – August 30, 2012
QLT Inc
It was unfortunate that most of QLT's potentail products never made it past PHASE II trials.
Senior Territory Account Manager (Former Employee), Philadelphia, PA – August 17, 2012
